Restoration of wild-type p53 activity by inhibition of Δ133p53 and the resulting degradation of TRF2 [26,27] may cause telomere uncapping-induced senescence or apoptosis through the TRF2-ATM-p53 positive feedback loop in cancers with wild-type p53. The gene discussed is TP53; the disease is cancer.